ResearcherThomas Jefferson UniversityNo recent work listed
Christopher Y. Kang
Matched on OpenAlex author ID A5102059443. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2013: 1 paper · 2014: 2 papers · 2015: none · 2016: 1 paper
Papers 4
- Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. Co-author DOI 10.1155/2016/2454989↗
- Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-013-2326-y↗
- Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation o… Co-author DOI 10.1007/s11605-013-2370-7↗
- Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcino… Co-author DOI 10.1245/s10434-013-3128-x↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Konrad Sarosiek · 4 shared papers, 2013–2016 · strength 0.18
- Paper Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. DOI 10.1155/2016/2454989↗
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. DOI 10.1007/s11605-013-2326-y↗
- Hwyda A. Arafat · 4 shared papers, 2013–2016 · strength 0.18
- Paper Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. DOI 10.1155/2016/2454989↗
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. DOI 10.1007/s11605-013-2326-y↗
- Charles J. Yeo · 4 shared papers, 2013–2016 · strength 0.18
- Paper Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. DOI 10.1155/2016/2454989↗
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. DOI 10.1007/s11605-013-2326-y↗
- Shivam Saxena · 3 shared papers, 2013–2016 · strength 0.14
- Paper Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. DOI 10.1155/2016/2454989↗
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological fe… DOI 10.1245/s10434-013-3128-x↗
- Ankit V. Gandhi · 3 shared papers, 2013–2016 · strength 0.14
- Paper Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. DOI 10.1155/2016/2454989↗
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological fe… DOI 10.1245/s10434-013-3128-x↗
- Mazhar Salim Al Zoubi · 2 shared papers, 2014 · strength 0.08
- Daniel M. Relles · 2 shared papers, 2013–2014 · strength 0.08
- Paper Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces f… DOI 10.1007/s11605-013-2370-7↗
- Paper Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological fe… DOI 10.1245/s10434-013-3128-x↗
- Mon‐Li Chu · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.